16
Participants
Start Date
March 31, 2006
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Nelfinavir mesylate, 625 mg
Nelfinavir 625 mg \[dosed orally as 1250 mg BID (two 625 mg tablets given orally BID)\] plus Combivir (lamivudine 150 mg plus zidovudine 300 mg BID dosed orally) administered with food. Subjects will start treatment at their baseline visit. Subjects will be treated for up to 26 weeks during pregnancy plus 6 weeks postpartum.
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Jacksonville
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Detroit
Pfizer Investigational Site, Metairie
Pfizer Investigational Site, Toronto
Lead Sponsor
Pfizer
INDUSTRY